Skip to content
    Mass General Brigham Ventures logo

    Mass General Brigham Ventures

    Somerville, Massachusetts, United StatesFounded 2008
    www.massgeneralbrigham.org/en/research-and-innovation/innovation/venturesLinkedIn
    Biotech & Life SciencesHealthcare

    Mass General Brigham Ventures is the corporate venture capital arm of the Mass General Brigham health system, founded in 2008 to invest in early-stage life science and healthcare companies emerging from the system's research and innovation pipeline.

    Average disclosed round size is $47.0M (across 25 rounds with reported amounts).

    Find people at Mass General Brigham Ventures on Goldilocks AI

    Portfolio

    22

    Fund Size

    —

    Top Stage

    Series B

    Last 12 Mo

    3

    Team

    AK

    Anne Klibanski, MD

    President & CEO, Mass General Brigham

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    26 investments
    CompanyRoundAmountDate
    InStride Health logoInStride HealthSeries C$30MJun 2026
    InStride logoInStrideSeries C$30MJun 2026
    CClaris BioSeries B—Jan 2026
    Carta Healthcare logoCarta HealthcareSeries B$18.3MMay 2025
    AAbcuro, Inc.Series C$200MFeb 2025
    Claris logoClarisSeries A$57MJan 2024
    InStride Health logoInStride HealthSeries B$30MJan 2024
    InStride logoInStrideSeries B$30MJan 2024
    Violet Therapeutics logoViolet TherapeuticsSeed$10.6MMay 2023
    VViolet Therapeutics Inc.Seed$10.6MMay 2023
    Rippl logoRipplSeed$32MSep 2022
    Photys logoPhotysSeries A$75MSep 2022
    Dexcare logoDexcareSeries B$50MJan 2022
    SSyntimmuneSeries B$50MJan 2017
    SSyntimmuneSeries A$8MJan 2016
    SSyntimmuneUnknown$8MJan 2014
    Abcuro logoAbcuroSeries C$200M—
    AAffinia TherapeuticsSeries C$40M—
    Nocion Therapeutics logoNocion TherapeuticsSeries B$62M—
    SSeQure DxSeries A$17.5M—
    Rome logoRomeUnknown$72M—
    NNocionSeries B$62M—
    PPredictaSeries A$23.4M—
    SSeQureSeries A$17.5M—
    Violet logoVioletSeed$10.6M—
    Page 1 of 2

    Top Co-Investors

    General Catalyst6 shared
    Valtruis5 shared
    .406 Ventures5 shared
    RA Capital Management4 shared
    Dementia Discovery Fund3 shared
    Ono Venture Investment3 shared
    UTEC3 shared
    F-Prime Capital3 shared
    Sanofi Ventures3 shared
    Samsara BioCapital3 shared
    Alexandria Venture Investments3 shared
    Arkin Bio Ventures3 shared
    FMZ Ventures3 shared
    Frist Cressey Ventures2 shared
    GV2 shared
    ARCH Venture Partners2 shared
    Pontifax2 shared
    Bain Capital Life Sciences2 shared
    Soleus Capital2 shared
    Foresite Capital2 shared

    Last updated: 9 September 2026